Authors:
Grabenbauer, GG
Rodel, C
Brunner, T
Schulze-Mosgau, S
Strnad, V
Muller, RG
Iro, H
Sauer, R
Citation: Gg. Grabenbauer et al., Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx - Review of 318 patients treated between 1985 and 1997, STRAH ONKOL, 177(7), 2001, pp. 338-344
Authors:
Marx, M
Beck, JD
Grabenbauer, GG
Dorr, HG
Citation: M. Marx et al., Spontaneous nocturnal growth hormone secretion in children after medulloblastoma therapy, MED PED ONC, 36(4), 2001, pp. 494-496
Authors:
Beck, A
Pazolt, D
Grabenbauer, GG
Nicholls, JM
Herbst, H
Young, LS
Niedobitek, G
Citation: A. Beck et al., Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease, J PATHOLOGY, 194(2), 2001, pp. 145-151
Authors:
Brunner, TB
Grabenbauer, GG
Kastl, S
Herrmann, O
Baum, U
Fietkau, R
Klein, P
Bautz, W
Schneider, T
Hohenberger, W
Sauer, R
Citation: Tb. Brunner et al., Preoperative chemoradiation in locally advanced pancreatic carcinoma: A phase II study, ONKOLOGIE, 23(5), 2000, pp. 436-442
Authors:
Grabenbauer, GG
Muhlfriedel, C
Rodel, F
Niedobitek, G
Hornung, J
Rodel, C
Martus, P
Iro, H
Kirchner, T
Steininger, H
Sauer, R
Weidenbecher, M
Distel, L
Citation: Gg. Grabenbauer et al., Squamous cell carcinoma of the oropharynx: Ki-67 and p53 can identify patients at high risk for local recurrence after surgery and postoperative radiotherapy, INT J RAD O, 48(4), 2000, pp. 1041-1050
Authors:
Rodel, C
Grabenbauer, GG
Rodel, F
Birkenhake, S
Kuhn, R
Martus, P
Zorcher, T
Fursich, D
Papadopoulos, T
Dunst, J
Schrott, KM
Sauer, R
Citation: C. Rodel et al., Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: Possible predictors for response to radiochemotherapy and successful bladder preservation, INT J RAD O, 46(5), 2000, pp. 1213-1221
Authors:
Rodel, C
Grabenbauer, GG
Schick, C
Papadopoulos, T
Hohenberger, W
Sauer, R
Citation: C. Rodel et al., Preoperative radiation with concurrent 5-fluorouracil for locally advancedT4-primary rectal cancer, STRAH ONKOL, 176(4), 2000, pp. 161-167
Citation: Gg. Grabenbauer, May 30 Gy be an adequate dose in patients with anal cancer treated with excisional biopsy followed by chemoradiotherapy?, STRAH ONKOL, 176(2), 2000, pp. 96-96
Authors:
Grabenbauer, GG
Schuchardt, U
Buchfelder, M
Rodel, CM
Gusek, G
Marx, M
Doerr, HG
Fahlbusch, R
Huk, WJ
Wenzel, D
Sauer, R
Citation: Gg. Grabenbauer et al., Radiation therapy of optico-hypothalamic gliomas (OHG) - radiographic response, vision and late toxicity, RADIOTH ONC, 54(3), 2000, pp. 239-245
Authors:
Anders, K
Grabenbauer, GG
Schuchardt, U
Fahlbusch, R
Fietkau, R
Sauer, R
Krauseneck, P
Citation: K. Anders et al., Accelerated radiotherapy with concomitant ACNU/Ara-C for the treatment of malignant glioma, J NEURO-ONC, 48(1), 2000, pp. 63-73
Authors:
Rodel, C
Grabenbauer, GG
Matzel, KE
Schick, C
Fietkau, R
Papadopoulos, T
Martus, P
Hohenberger, W
Sauer, R
Citation: C. Rodel et al., Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer, DIS COL REC, 43(3), 2000, pp. 312-319
Authors:
Sauer, R
Schuchardt, U
Hohenberger, W
Wittekind, C
Papadopoulos, T
Grabenbauer, GG
Fietkau, R
Citation: R. Sauer et al., Preoperative radiochemotherapy in soft tissue sarcomas for improving localtumor control and postoperative functional outcome, STRAH ONKOL, 175(6), 1999, pp. 259-266
Citation: Gg. Grabenbauer, Randomized trial of high-dose chemotherapy and hemopoietic progenitor-cellsupport in operable breast cancer with extensive axillary lymph-node involvement, STRAH ONKOL, 175(2), 1999, pp. 85-86
Citation: U. Baum et Gg. Grabenbauer, Thin-section helical CT is superior to MR imaging in the assessment of local extension of pancreatic carcinoma - Commentary, STRAH ONKOL, 175(11), 1999, pp. 583-584
Authors:
Honegger, J
Grabenbauer, GG
Paulus, W
Fahlbusch, R
Citation: J. Honegger et al., Regression of a large solid papillary craniopharyngioma following fractionated external radiotherapy, J NEURO-ONC, 41(3), 1999, pp. 261-266